Near full length hepatitis C virus genome reconstruction by next generation sequencing based on genotype-independent amplification

Digestive and Liver Disease

Volumn 47, Issue 7, 2015, Pages 608-612

  Bartolini, Barbara ^a   Giombini, Emanuela ^a   Abbate, Isabella ^a   Selleri, Marina ^a   Rozera, Gabriella ^a   Biagini, Tommaso ^b   Visco Comandini, Ubaldo ^a   Taibi, Chiara ^a   Capobianchi, Maria Rosaria ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

DAAs; Deep sequencing; Full genome reconstruction; HCV; Modified SISPA approach

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; NEXT GENERATION SEQUENCING; PHYLOGENY; PRIORITY JOURNAL; PYROSEQUENCING; VERY ELDERLY; VIRUS GENOME; VIRUS LOAD; DNA SEQUENCE; GENETICS; GENOTYPING TECHNIQUE; HEPACIVIRUS; HEPATITIS C; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; PROCEDURES; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY;

VIRUS DNA; VIRUS RNA;

AGED; AGED, 80 AND OVER; DNA, VIRAL; FEMALE; GENOME, VIRAL; GENOTYPE; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 84937627865     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2015.03.015     Document Type: Article

References (21)

1. Quiñones-Mateu M.E., Avila S., Reyes-Teran G., et al. Deep sequencing: becoming a critical tool in clinical virology. Journal of Clinical Virology 2014, 61:9-19. 10.1016/j.jcv.2014.06.013.
2. Capobianchi M.R., Giombini E., Rozera G. Next-generation sequencing technologies in diagnostic virology. Clinical Microbiology and Infection 2013, 19:15-22.
3. Barzon L., Lavezzo E., Costanzi G., et al. Journal of Clinical Virology 2013, 58:346-350.
4. Bartolini B., Chillemi G., Abbate I., et al. Assembly and characterization of pandemic influenza A H1N1 genome in nasopharyngeal swabs using high-throughput pyrosequencing. New Microbiologica 2011, 34:391-397.
5. Bruselles A., Rozera G., Bartolini B., et al. Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV type 1 BF recombinant associated with a fatal primary infection. AIDS Research and Human Retroviruses 2009, 25:937-942. 10.1089/aid.2009.0083.
6. Cortés K.C., Zagordi O., Perlejewski K., et al. Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome. BMC Infectious Diseases 2014, 14:389. 10.1186/1471-2334-14-389.
7. Cento V., Tontodonati M., Di Maio V.C., et al. Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice. Digestive and Liver Disease 2014, 10.1016/j.dld.2014.12.004.
8. Allander T., Tammi M.T., Eriksson M., et al. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:12891-12896.
9. Djikeng A., Halpin R., Kuzmickas R., et al. Viral genome sequencing by random priming methods. BMC Genomics 2008, 7:5. 10.1186/1471-2164-9-5.
10. Kircher M., Kelso J. High-throughput DNA sequencing - concepts and limitations. Bioassays 2010, 32:524-536.
11. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Research 2004, 32:1792-1797.
12. Posada D., Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14:817-818.
13. Tamura K., Peterson D., Peterson N., et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Molecular Biology and Evolution 2011, 28:2731-2739.
14. Simmonds P.S.S.E. A nucleotide and amino acid sequence analysis platform. BMC Research Notes 2012, 5:50. 10.1186/1756-0500-5-50.
15. Rosseel T., Van Borm S., Vandenbussche F., et al. The origin of biased sequence depth in sequence-independent nucleic acid amplification and optimization for efficient massive parallel sequencing. PLOS ONE 2013, 26(8):e76144. 10.1371/journal.pone.0076144.
16. Petty T.J., Cordey S., Padioleau I., et al. Comprehensive human virus screening using high-throughput sequencing with a user-friendly representation of bioinformatics analysis: a pilot study. Journal of Clinical Microbiology 2014, 9. pii:JCM.01389-14.
17. Radford A.D., Chapman D., Dixon L., et al. Application of next-generation sequencing technologies in virology. Journal of General Virology 2012, 93:1853-1868.
18. Bartels D.J., Sullivan J.C., Zhang E.Z., et al. Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment. Journal of Virology 2013, 87:1544-1553. 10.1128/JVI. 02294-12.
19. Bartolini B., Giombini E., Zaccaro P., et al. Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients. Virus Research 2013, 6:205-208. 10.1016/j.virusres.2013.08.001.
20. Berger K.L., Triki I., Cartier M., et al. Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir. Antimicrobial Agents and Chemotherapy 2014, 58:698-705. 10.1128/AAC.01976-13.
21. Jabara C.B., Jones C.D., Roach J., et al. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:20166-20171. 10.1073/pnas.1110064108.